Dare Bioscience Inc (NAS:DARE)
$ 3.18 -0.01 (-0.31%) Market Cap: 27.67 Mil Enterprise Value: 17.93 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 32/100

Q3 2019 Dare Bioscience Inc Earnings Call Transcript

Nov 14, 2019 / 09:30PM GMT
Release Date Price: $9 (-4.46%)
Operator

Welcome to the conference call hosted by Daré Bioscience to review financial results for the quarter ending September 30, 2019, and to provide a general business update. This call is being recorded. My name is Sarah, and I will be your operator today.

With us are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Chief Business Development Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer. Ms. Johnson, please proceed.

Sabrina Martucci Johnson;Bioscience
DarÃ;Inc. - President, CEO, Secretary & Director

© -

Thank you, and welcome to our financial results and business update call for Daré Bioscience. It's a pleasure to have the opportunity to talk about our third quarter results and our company highlights and upcoming milestones for the remainder of 2019 and 2020.

Before I begin, I would like to remind you that today's discussion will include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot